Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy J Eshleman

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
European Journal of Pharmacology|October 26, 2010
Melittin stimulates fatty acid release through non-phospholipase-mediated mechanisms and interacts with the dopamine transporter and other membrane-spanning proteinsDove J Keith, Amy J Eshleman, Aaron Janowsky
European Journal of Pharmacology|June 12, 2012
Melittin initiates dopamine transporter internalization and recycling in transfected HEK-293 cellsDove J Keith, Katherine Wolfrum, Amy J Eshleman, et al.
Journal of Neurochemistry|January 19, 2006
Hydrogen ion concentration differentiates effects of methamphetamine and dopamine on transporter-mediated effluxClare J Wilhelm, Robert A Johnson, Amy J Eshleman, et al.
Behavioural Brain Research|September 18, 2012
GABAB receptor activation attenuates the stimulant but not mesolimbic dopamine response to ethanol in FAST miceSarah E Holstein, Na Li, Amy J Eshleman, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 28, 2016
Rigid Adenine Nucleoside Derivatives as Novel Modulators of the Human Sodium Symporters for Dopamine and NorepinephrineAaron Janowsky, Dilip K Tosh, Amy J Eshleman, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|November 12, 2017
Verification of a genetic locus for methamphetamine intake and the impact of morphineEmily C Eastwood, Amy J Eshleman, Aaron Janowsky, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 9, 2011
Abuse liability profile of three substituted tryptaminesMichael B Gatch, Michael J Forster, Aaron Janowsky, et al.
Biochemical Pharmacology|January 15, 2008
Lobeline effects on tonic and methamphetamine-induced dopamine releaseClare J Wilhelm, Robert A Johnson, Amy J Eshleman, et al.
Molecular Pharmacology|August 15, 2019
Activation of Trace Amine-Associated Receptor 1 Stimulates an Antiapoptotic Signal Cascade via Extracellular Signal-Regulated Kinase 1/2Xiao Shi, Tracy L Swanson, Nicholas B Miner, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 23, 2004
Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model systemClare J Wilhelm, Robert A Johnson, Paul G Lysko, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|October 26, 2010
Melittin stimulates fatty acid release through non-phospholipase-mediated mechanisms and interacts with the dopamine transporter and other membrane-spanning proteinsDove J Keith, Amy J Eshleman, Aaron Janowsky
European Journal of Pharmacology|June 12, 2012
Melittin initiates dopamine transporter internalization and recycling in transfected HEK-293 cellsDove J Keith, Katherine Wolfrum, Amy J Eshleman, et al.
Journal of Neurochemistry|January 19, 2006
Hydrogen ion concentration differentiates effects of methamphetamine and dopamine on transporter-mediated effluxClare J Wilhelm, Robert A Johnson, Amy J Eshleman, et al.
Behavioural Brain Research|September 18, 2012
GABAB receptor activation attenuates the stimulant but not mesolimbic dopamine response to ethanol in FAST miceSarah E Holstein, Na Li, Amy J Eshleman, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 28, 2016
Rigid Adenine Nucleoside Derivatives as Novel Modulators of the Human Sodium Symporters for Dopamine and NorepinephrineAaron Janowsky, Dilip K Tosh, Amy J Eshleman, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|November 12, 2017
Verification of a genetic locus for methamphetamine intake and the impact of morphineEmily C Eastwood, Amy J Eshleman, Aaron Janowsky, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 9, 2011
Abuse liability profile of three substituted tryptaminesMichael B Gatch, Michael J Forster, Aaron Janowsky, et al.
Biochemical Pharmacology|January 15, 2008
Lobeline effects on tonic and methamphetamine-induced dopamine releaseClare J Wilhelm, Robert A Johnson, Amy J Eshleman, et al.
Molecular Pharmacology|August 15, 2019
Activation of Trace Amine-Associated Receptor 1 Stimulates an Antiapoptotic Signal Cascade via Extracellular Signal-Regulated Kinase 1/2Xiao Shi, Tracy L Swanson, Nicholas B Miner, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 23, 2004
Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model systemClare J Wilhelm, Robert A Johnson, Paul G Lysko, et al.
Pageof 4